ACS Omega · 2021 · 12 citations · 42 references
PharmacyFood ScienceNutritional SciencesBioavailabilityDrug DeliveryFood ChemistryCell EncapsulationDrug EncapsulationGastrointestinal ToxicityNanocarriers For Mucosal DeliveryNanoparticle-based BioavailabilityCapsule Loading CapacityDeoxynivalenol ContaminationDetoxificationEncapsulation EffectsGrowth Performance AssessmentMicroparticlesSimulated Gastric FluidSimulated Gastric Media
. The diameter of the SMBS containing microparticles was 511 ± 135 μm, and the loading capacity of SMBS in the microparticles was 45.50%; 1.41% of the encapsulated SMBS (ES) was released into the simulated gastric fluid, and 66.39% of ES was progressively released into the simulated intestinal fluid within 4 h at 37 °C. In IPEC-J2 cells, when DON was treated with the simulated gastric fluid containing 0.5% ES for 2 h, then mixed with the simulated intestinal fluid (1:1) and incubated for 2 h, cytotoxicity was not observed. DON treated with 0.5 ES decreased the gene expression of inflammatory cytokines in the cells compared with DON alone and maintained the cell integrity. To conclude, the SMBS containing microparticles were stable in the simulated gastric fluid and allowed a progressive release of SMBS in the simulated intestinal fluid. The released SMBS in the simulated intestinal fluid effectively detoxified DON.
42
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
W. Mehnert, Karsten Mäder · Advanced Drug Delivery Reviews · 2012 · 933 citations